NATHBIOGEN — Nath Bio-Genes (I) Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousMicro CapNeutral

Annual income statement for Nath Bio-Genes (I), fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,784	3,014	3,326	3,649	4,451
Cost of Revenue
Gross Profit	1,632	1,958	2,289	2,520	2,436
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,330	2,556	2,826	3,174	3,906
Operating Profit	-546	457	501	476	545
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-634	362	416	406	463
Provision for Income Taxes
Net Income After Taxes	-673	350	396	386	416
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-673	350	396	386	416
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-673	350	396	386	416
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-5.07	18.4	19.1	20.6	18.3
Dividends per Share